Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03412435

Asan Medical Center Myocardial Infarction Registry

This study evaluates long-term outcome of patients diagnosed as acute myocardial infarction and treated with medication, coronary artery bypass surgery and percutaneous coronary intervention in Asan medical center, Korea.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Myocardial Infarction, Acute Cardiovascular Diseases Coronary Disease Coronary Stenosis Heart Diseases Infarction Ischemia Myocardial Infarction Myocardial Ischemia Necrosis Pathologic Processes Pathological Conditions, Signs and Symptoms Vascular Diseases

Age range

19 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Asan Medical Center

Seoul, South Korea

Location status: Recruiting

Location contact

Seung-jung Park, MD

CONTACT

[email protected]

Seung-jung Park, MD

PRINCIPAL_INVESTIGATOR

About this study

This study will collect 3000 cases retrospectively and 2000 cases prospectively.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All consecutive acute myocardial infarction patients diagnosed through coronary angiography

Treatment and study plan

Primary outcomes

  1. A composite event of all-cause death, non-fatal myocardial infarction and repeat revascularization

    Time frame: 1 year

Secondary outcomes

  1. All cause death

    Time frame: 5 year

  2. Cardiac death

    Time frame: 5 year

  3. Myocardial infarction

    Time frame: 5 year

  4. A composite event of all-cause death and myocardial infarction

    Time frame: 5 year

  5. A composite event of cardiac death and myocardial infarction

    Time frame: 5 year

  6. Repeat revascularization

    Time frame: 5 year

  7. Stent thrombosis

    Time frame: 5 year

    according to Academic Research Consortium (ARC) criteria

  8. Stroke

    Time frame: 5 year

    A stroke or cerebrovascular accident with loss of neurological function caused by an ischemic or hemorrhagic event with residual symptoms at least 24 hours after onset or leading to death.

  9. Procedure success

    Time frame: 7 days

    Successful percutaneous coronary intervention at the intended target lesion with final instant residual stenosis of less than 30% by quantitative coronary angiography (QCA) and no event of death or Q wave myocardial infarction or urgent revascularization during hospitalization.

  10. Surgery success

    Time frame: 7 days

    Successful surgery defines as no event of death or Q wave myocardial infarction or urgent revascularization during hospitalization.

Study contacts

Contact information is provided by the study sponsor or research team.

Jung-hee Ham, RN

CONTACT

[email protected]

8230104728

Seung-jung Park, MD

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Seung-Jung Park

Other

Collaborators

  • CardioVascular Research Foundation, Korea

Registry information

Acronym: Asan-MI

Important dates

Study start
2018
Primary completion
2026
Study completion
2031
First posted
Jan 26, 2018
Registry last updated
Jan 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.